HART News 9.37 Harvard Apparatus Regenerative (HART)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Harvard Apparatus Regenerative (HART) 9.37 $HART

Harvard Apparatus Regenerative Technology Names Saverio La Francesca, MD as its Chief Medical Officer
Business Wire - Wed Apr 16, 8:30AM CDT
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, has hired Saverio La Francesca, MD, a veteran cardiothoracic surgeon and leading organ transplant physician, as the Company's first Chief Medical Officer, effective April 14.

Harvard Apparatus Regenerative Technology Collaborator Successfully Transplants Regenerated Esophagus into Rat
Business Wire - Tue Apr 15, 11:23AM CDT
--Research to Be Presented at the American Association for Thoracic Surgery (AATS) Annual Meeting 2014 in Toronto

I’m Selling Harvard Biosciences
Jim Royal, The Motley Fool - Motley Fool - Thu Mar 27, 3:31PM CDT
My Special Situations portfolio took a stake in Harvard Bioscience before its recently completed spinoff of Harvard Apparatus Regenerative Technology . That was in January of last year, and the combined position has risen about 39%. Not bad....

Harvard Apparatus Regenerative Technology CEO David Green Interviewed on Bloomberg Television
Business Wire - Thu Mar 27, 6:00AM CDT
David Green, CEO of Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was interviewed on Bloomberg TV's "Market Makers" program on March 26.

Harvard Apparatus Regenerative Technology Spotlighted by Fast Company Co.Exist
Business Wire - Fri Mar 21, 6:00AM CDT
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was featured in an article published by Fast Company Co.Exist on March 19.

Harvard Apparatus Regenerative Technology Posts Updated Investor Presentation on Its Website
Business Wire - Fri Mar 14, 6:00AM CDT
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, has posted an updated version of its investor presentation on its website.

Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Year Ended December 31, 2013 Operating Results
Business Wire - Fri Mar 07, 6:00AM CST
Harvard Apparatus Regenerative Technology, Inc. (Nasdaq: HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, today reported unaudited financial results for the three months and year ended December 31, 2013.

Harvard Apparatus Regenerative Technology Schedules Release of Fourth Quarter and Year-End 2013 Financial Results and Investor Teleconference for March 7th
Business Wire - Mon Mar 03, 12:45PM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ: HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will announce results of its fourth quarter and year ended December 31, 2013 before market trading hours on Friday, March 7, 2014. A conference call to discuss the company's fourth quarter and year-end results is scheduled for that same day at 11:00 AM (Eastern Time).

Harvard Apparatus Regenerative Technology to Present at 2nd Annual Regen Med Investor Day in New York City
Business Wire - Thu Feb 27, 6:00AM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will present at the 2nd Annual Regen Med Investor Day in New York City on March 26, 2014. David Green, CEO of Harvard Apparatus Regenerative Technology, will provide an overview of the company, its clinical developments and milestones.

Harvard Apparatus Regenerative Technology Collaboration with Texas Heart Institute Profiled by Houston's NBC-TV Affiliate on February 19
Business Wire - Wed Feb 26, 6:00AM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was featured February 19 in a television segment and article reported by the NBC-TV affiliate in Houston (KPRC-TV).

Harvard Apparatus Regenerative Technology Profiled by Xconomy.com
Business Wire - Mon Feb 24, 6:00AM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was featured in an article published by Xconomy.com on February 18.

Harvard Apparatus Regenerative Technology Spotlighted by Investor's Business Daily
Business Wire - Wed Feb 05, 6:00AM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was spotlighted in an article published by Investor's Business Daily on February 3.

Harvard Apparatus Regenerative Technology Profiled by MIT Technology Review
Business Wire - Fri Jan 17, 6:00AM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was featured in an article published by MIT Technology Review on January 16.

Harvard Apparatus Regenerative Technology To Present at Biotech Showcase 2014 and OneMedForum 2014 in San Francisco
Business Wire - Tue Jan 07, 5:59AM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will present at Biotech Showcase(TM) 2014 and OneMedForum 2014, both in San Francisco, on January 13, 2014. David Green, CEO of Harvard Apparatus Regenerative Technology, will provide an overview of the company, its clinical developments and milestones.

Harvard Apparatus Regenerative Technology Files Pre-IND Meeting Documents and Orphan Biologics Application with U.S. Food and Drug Administration
Business Wire - Mon Jan 06, 5:59AM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, has filed its pre-Investigational New Drug (IND) meeting documents with the U.S. Food and Drug Administration (FDA). The company expects the pre-IND meeting to take place by the end of January 2014.

Harvard Apparatus Regenerative Technology Profiled by Boston's ABC-TV Affiliate on November 27
Business Wire - Mon Dec 02, 10:50AM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ: HART), a biotechnology company developing regenerative medicine therapies, initially for trachea cancer, was featured November 27 in a television segment and article reported by the ABC-TV affiliate in Boston (WCVB-TV).

Harvard Apparatus Regenerative Technology Profiled by Boston Globe and WBZ-AM CBS NewsRadio Boston
Business Wire - Thu Nov 21, 6:05AM CST
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a biotechnology company developing regenerative medicine therapies, initially for trachea cancer, was featured recently in the Boston Globe and in a radio report and article from WBZ-AM CBS NewsRadio Boston.

Harvard Apparatus Regenerative Technology Shares to Begin Trading Today Under NASDAQ Ticker Symbol HART
Business Wire - Mon Nov 04, 6:00AM CST
Effective today, Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a biotechnology company developing regenerative medicine therapies, initially for trachea cancer, has begun trading on the NASDAQ exchange under the ticker symbol HART after being spun off by Harvard Bioscience, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New York Reclaims Bagel Crown at 2026 BagelFest

Updated Category News Views 147

A Bagel Victory at Citi Field Holy schmear! New Yorker's are grinning wide like a bagel with a double helping of cream cheese—Ess-a-Bagel from Manhattan snagged the top honors at the heavily contested 2026 New York BagelFest. Back in its rightful hands, the Bagel Crown stays in the Empire State, and it's a victory for tradition and taste. Celebrating 50 years in the...

Continue Reading
SGRY Acquisition Under Scrutiny: Fairness Questioned

Updated Category News Views 124

Questions Hover Over SGRY Acquisition Here's a real jaw-dropper for you. Surgery Partners, Inc. (NASDAQ: SGRY) is getting clocks cleaned in a fairness probe over its acquisition terms. If you thought this ride was smooth, think again—Levi & Korsinsky, LLP has put the brakes on any such assumptions, launching an investigation that’s sure to raise some eyebrows. What's...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 71

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
Trades Workforce Shortage Costs Wallop U.S. Economy

Updated Category News Views 113

The Forgotten Backbone of America Don't sleep on this: America's got itself a trade worker crisis, and it's not just a numerical hiccup. We’re down nearly 1.9 million skilled trades workers, and that's a gut punch to the economy—a hefty $1.2 billion a day in GDP loss. These are the folks who keep the wheels greased, the lights on, and the goods flowing. Without them,...

Continue Reading
Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 54

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 250

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 58

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 126

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 152

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 62

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading

Top 5 Most Recently Viewed Articles

Eimskip's Q3 2025 Financial Overview and Future Outlook

Updated Category News Views 238

Eimskip's Third Quarter Performance Analysis The results for the third quarter of 2025 have presented challenges for Eimskip, as operations did not meet expectations. Revenues showed significant shifts, revealing both obstacles and opportunities in the company's journey. Operational Insights During Q3, Eimskip experienced a slight increase in liner shipping volumes,...

Continue Reading
Market Trends and Insights: The Bullish Moves on Block

Updated Category News Views 88

Examining Recent Bullish Moves on Block Recently, financial institutions have been making significant bullish strides into Block, a company known for its innovative payment services. Analysis of the options trading history for Block (NASDAQ: SQ) indicates a noticeable interest, with 16 unusual trades captured, providing insights into market direction and trader sentiment....

Continue Reading
Exploring the Soaring Online Poker Market Growth Trends

Updated Category News Views 157

Online Poker Market: A Surge on the Horizon The Global Online Poker Market is currently undergoing a transformative expansion, predicted to rise from USD 7.98 billion in 2024 to an impressive USD 37.19 billion by 2030. This notable growth reflects a compound annual growth rate (CAGR) of 29.24%, driven by advancements in technology such as enhanced smartphone capabilities,...

Continue Reading
Elevate Your Gaming with Jackbit's New Crypto Welcome Offer

Updated Category News Views 182

Jackbit’s New Welcome Bonus for Crypto Players As online gaming evolves, Jackbit Crypto Casino is launching an exciting new welcome bonus tailored specifically for cryptocurrency enthusiasts. Starting next year, all new players joining the Jackbit platform will enjoy the same welcome bonuses that traditional fiat customers have been taking advantage of. This bold move...

Continue Reading
Eli Lilly's Mounjaro Drug Set to Revolutionize Weight Loss in Hong Kong

Updated Category News Views 214

Eli Lilly to Launch Weight Loss Drug Mounjaro in Hong Kong Eli Lilly & Co. (NYSE: LLY) is poised to launch its well-regarded weight-loss medication, Mounjaro, in Hong Kong shortly. This marks an exciting milestone, as it positions Mounjaro to be the first of its kind available in the broader region of China. The anticipated launch follows recent reports indicating that...

Continue Reading